 | • レポートコード：MRC2-11QY02093 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、116ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はADHD治療薬のグローバル市場について調査・分析したレポートです。種類別（覚醒剤（アンフェタミン、メチルフェニデート）、非覚醒剤、抗うつ剤、血圧薬）市場規模、用途別（大人用、子供用）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別ADHD治療薬の競争状況、市場シェア ・世界のADHD治療薬市場：種類別市場規模 2015年-2020年（覚醒剤（アンフェタミン、メチルフェニデート）、非覚醒剤、抗うつ剤、血圧薬） ・世界のADHD治療薬市場：種類別市場規模予測 2021年-2026年（覚醒剤（アンフェタミン、メチルフェニデート）、非覚醒剤、抗うつ剤、血圧薬） ・世界のADHD治療薬市場：用途別市場規模 2015年-2020年（大人用、子供用） ・世界のADHD治療薬市場：用途別市場規模予測 2021年-2026年（大人用、子供用） ・北米のADHD治療薬市場分析：米国、カナダ ・ヨーロッパのADHD治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのADHD治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のADHD治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのADHD治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Eli Lilly、Janssen Pharmaceuticals, Inc.、Takeda、Perdue Pharma、Glaxosmith Kline、Novartis、Celltech Group、Johnson & Johnson ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global ADHD Drugs Market
The global ADHD Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global ADHD Drugs Scope and Market Size
ADHD Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global ADHD Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the ADHD Drugs market is segmented into
Stimulants (Amphetamines, Methylphenidate)
Non-Stimulants
Antidepressants
Blood Pressure Medicines
Segment by Application, the ADHD Drugs market is segmented into
Adults
Children
Regional and Country-level Analysis
The ADHD Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the ADHD Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and ADHD Drugs Market Share Analysis
ADHD Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in ADHD Drugs business, the date to enter into the ADHD Drugs market, ADHD Drugs product introduction, recent developments, etc.
The major vendors covered:
Eli Lilly
Janssen Pharmaceuticals, Inc.
Takeda
Perdue Pharma
Glaxosmith Kline
Novartis
Celltech Group
Johnson & Johnson
1 Study Coverage
1.1 ADHD Drugs Product Introduction
1.2 Market Segments
1.3 Key ADHD Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global ADHD Drugs Market Size Growth Rate by Type
1.4.2 Stimulants (Amphetamines, Methylphenidate)
1.4.3 Non-Stimulants
1.4.4 Antidepressants
1.4.5 Blood Pressure Medicines
1.5 Market by Application
1.5.1 Global ADHD Drugs Market Size Growth Rate by Application
1.5.2 Adults
1.5.3 Children
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global ADHD Drugs Market Size, Estimates and Forecasts
2.1.1 Global ADHD Drugs Revenue 2015-2026
2.1.2 Global ADHD Drugs Sales 2015-2026
2.2 Global ADHD Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global ADHD Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global ADHD Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global ADHD Drugs Competitor Landscape by Players
3.1 ADHD Drugs Sales by Manufacturers
3.1.1 ADHD Drugs Sales by Manufacturers (2015-2020)
3.1.2 ADHD Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 ADHD Drugs Revenue by Manufacturers
3.2.1 ADHD Drugs Revenue by Manufacturers (2015-2020)
3.2.2 ADHD Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global ADHD Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by ADHD Drugs Revenue in 2019
3.2.5 Global ADHD Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 ADHD Drugs Price by Manufacturers
3.4 ADHD Drugs Manufacturing Base Distribution, Product Types
3.4.1 ADHD Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers ADHD Drugs Product Type
3.4.3 Date of International Manufacturers Enter into ADHD Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global ADHD Drugs Market Size by Type (2015-2020)
4.1.1 Global ADHD Drugs Sales by Type (2015-2020)
4.1.2 Global ADHD Drugs Revenue by Type (2015-2020)
4.1.3 ADHD Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global ADHD Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global ADHD Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global ADHD Drugs Revenue Forecast by Type (2021-2026)
4.2.3 ADHD Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global ADHD Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global ADHD Drugs Market Size by Application (2015-2020)
5.1.1 Global ADHD Drugs Sales by Application (2015-2020)
5.1.2 Global ADHD Drugs Revenue by Application (2015-2020)
5.1.3 ADHD Drugs Price by Application (2015-2020)
5.2 ADHD Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global ADHD Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global ADHD Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global ADHD Drugs Price Forecast by Application (2021-2026)
6 North America
6.1 North America ADHD Drugs by Country
6.1.1 North America ADHD Drugs Sales by Country
6.1.2 North America ADHD Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America ADHD Drugs Market Facts & Figures by Type
6.3 North America ADHD Drugs Market Facts & Figures by Application
7 Europe
7.1 Europe ADHD Drugs by Country
7.1.1 Europe ADHD Drugs Sales by Country
7.1.2 Europe ADHD Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe ADHD Drugs Market Facts & Figures by Type
7.3 Europe ADHD Drugs Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific ADHD Drugs by Region
8.1.1 Asia Pacific ADHD Drugs Sales by Region
8.1.2 Asia Pacific ADHD Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific ADHD Drugs Market Facts & Figures by Type
8.3 Asia Pacific ADHD Drugs Market Facts & Figures by Application
9 Latin America
9.1 Latin America ADHD Drugs by Country
9.1.1 Latin America ADHD Drugs Sales by Country
9.1.2 Latin America ADHD Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America ADHD Drugs Market Facts & Figures by Type
9.3 Central & South America ADHD Drugs Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa ADHD Drugs by Country
10.1.1 Middle East and Africa ADHD Drugs Sales by Country
10.1.2 Middle East and Africa ADHD Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa ADHD Drugs Market Facts & Figures by Type
10.3 Middle East and Africa ADHD Drugs Market Facts & Figures by Application
11 Company Profiles
11.1 Eli Lilly
11.1.1 Eli Lilly Corporation Information
11.1.2 Eli Lilly Description and Business Overview
11.1.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Eli Lilly ADHD Drugs Products Offered
11.1.5 Eli Lilly Related Developments
11.2 Janssen Pharmaceuticals, Inc.
11.2.1 Janssen Pharmaceuticals, Inc. Corporation Information
11.2.2 Janssen Pharmaceuticals, Inc. Description and Business Overview
11.2.3 Janssen Pharmaceuticals, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Janssen Pharmaceuticals, Inc. ADHD Drugs Products Offered
11.2.5 Janssen Pharmaceuticals, Inc. Related Developments
11.3 Takeda
11.3.1 Takeda Corporation Information
11.3.2 Takeda Description and Business Overview
11.3.3 Takeda Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Takeda ADHD Drugs Products Offered
11.3.5 Takeda Related Developments
11.4 Perdue Pharma
11.4.1 Perdue Pharma Corporation Information
11.4.2 Perdue Pharma Description and Business Overview
11.4.3 Perdue Pharma Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Perdue Pharma ADHD Drugs Products Offered
11.4.5 Perdue Pharma Related Developments
11.5 Glaxosmith Kline
11.5.1 Glaxosmith Kline Corporation Information
11.5.2 Glaxosmith Kline Description and Business Overview
11.5.3 Glaxosmith Kline Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Glaxosmith Kline ADHD Drugs Products Offered
11.5.5 Glaxosmith Kline Related Developments
11.6 Novartis
11.6.1 Novartis Corporation Information
11.6.2 Novartis Description and Business Overview
11.6.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Novartis ADHD Drugs Products Offered
11.6.5 Novartis Related Developments
11.7 Celltech Group
11.7.1 Celltech Group Corporation Information
11.7.2 Celltech Group Description and Business Overview
11.7.3 Celltech Group Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Celltech Group ADHD Drugs Products Offered
11.7.5 Celltech Group Related Developments
11.8 Johnson & Johnson
11.8.1 Johnson & Johnson Corporation Information
11.8.2 Johnson & Johnson Description and Business Overview
11.8.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Johnson & Johnson ADHD Drugs Products Offered
11.8.5 Johnson & Johnson Related Developments
11.1 Eli Lilly
11.1.1 Eli Lilly Corporation Information
11.1.2 Eli Lilly Description and Business Overview
11.1.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Eli Lilly ADHD Drugs Products Offered
11.1.5 Eli Lilly Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 ADHD Drugs Market Estimates and Projections by Region
12.1.1 Global ADHD Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global ADHD Drugs Revenue Forecast by Regions 2021-2026
12.2 North America ADHD Drugs Market Size Forecast (2021-2026)
12.2.1 North America: ADHD Drugs Sales Forecast (2021-2026)
12.2.2 North America: ADHD Drugs Revenue Forecast (2021-2026)
12.2.3 North America: ADHD Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe ADHD Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: ADHD Drugs Sales Forecast (2021-2026)
12.3.2 Europe: ADHD Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: ADHD Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific ADHD Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: ADHD Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: ADHD Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: ADHD Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America ADHD Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: ADHD Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: ADHD Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: ADHD Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa ADHD Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: ADHD Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: ADHD Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: ADHD Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key ADHD Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 ADHD Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. ADHD Drugs Market Segments
Table 2. Ranking of Global Top ADHD Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global ADHD Drugs Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Stimulants (Amphetamines, Methylphenidate)
Table 5. Major Manufacturers of Non-Stimulants
Table 6. Major Manufacturers of Antidepressants
Table 7. Major Manufacturers of Blood Pressure Medicines
Table 8. Global ADHD Drugs Market Size Growth Rate by Application 2020-2026 (K Units)
Table 9. Global ADHD Drugs Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 10. Global ADHD Drugs Sales by Regions 2015-2020 (K Units)
Table 11. Global ADHD Drugs Sales Market Share by Regions (2015-2020)
Table 12. Global ADHD Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 13. Global ADHD Drugs Sales by Manufacturers (2015-2020) (K Units)
Table 14. Global ADHD Drugs Sales Share by Manufacturers (2015-2020)
Table 15. Global ADHD Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 16. Global ADHD Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in ADHD Drugs as of 2019)
Table 17. ADHD Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 18. ADHD Drugs Revenue Share by Manufacturers (2015-2020)
Table 19. Key Manufacturers ADHD Drugs Price (2015-2020) (USD/Unit)
Table 20. ADHD Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers ADHD Drugs Product Type
Table 22. Date of International Manufacturers Enter into ADHD Drugs Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Global ADHD Drugs Sales by Type (2015-2020) (K Units)
Table 25. Global ADHD Drugs Sales Share by Type (2015-2020)
Table 26. Global ADHD Drugs Revenue by Type (2015-2020) (US$ Million)
Table 27. Global ADHD Drugs Revenue Share by Type (2015-2020)
Table 28. ADHD Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 29. Global ADHD Drugs Sales by Application (2015-2020) (K Units)
Table 30. Global ADHD Drugs Sales Share by Application (2015-2020)
Table 31. North America ADHD Drugs Sales by Country (2015-2020) (K Units)
Table 32. North America ADHD Drugs Sales Market Share by Country (2015-2020)
Table 33. North America ADHD Drugs Revenue by Country (2015-2020) (US$ Million)
Table 34. North America ADHD Drugs Revenue Market Share by Country (2015-2020)
Table 35. North America ADHD Drugs Sales by Type (2015-2020) (K Units)
Table 36. North America ADHD Drugs Sales Market Share by Type (2015-2020)
Table 37. North America ADHD Drugs Sales by Application (2015-2020) (K Units)
Table 38. North America ADHD Drugs Sales Market Share by Application (2015-2020)
Table 39. Europe ADHD Drugs Sales by Country (2015-2020) (K Units)
Table 40. Europe ADHD Drugs Sales Market Share by Country (2015-2020)
Table 41. Europe ADHD Drugs Revenue by Country (2015-2020) (US$ Million)
Table 42. Europe ADHD Drugs Revenue Market Share by Country (2015-2020)
Table 43. Europe ADHD Drugs Sales by Type (2015-2020) (K Units)
Table 44. Europe ADHD Drugs Sales Market Share by Type (2015-2020)
Table 45. Europe ADHD Drugs Sales by Application (2015-2020) (K Units)
Table 46. Europe ADHD Drugs Sales Market Share by Application (2015-2020)
Table 47. Asia Pacific ADHD Drugs Sales by Region (2015-2020) (K Units)
Table 48. Asia Pacific ADHD Drugs Sales Market Share by Region (2015-2020)
Table 49. Asia Pacific ADHD Drugs Revenue by Region (2015-2020) (US$ Million)
Table 50. Asia Pacific ADHD Drugs Revenue Market Share by Region (2015-2020)
Table 51. Asia Pacific ADHD Drugs Sales by Type (2015-2020) (K Units)
Table 52. Asia Pacific ADHD Drugs Sales Market Share by Type (2015-2020)
Table 53. Asia Pacific ADHD Drugs Sales by Application (2015-2020) (K Units)
Table 54. Asia Pacific ADHD Drugs Sales Market Share by Application (2015-2020)
Table 55. Latin America ADHD Drugs Sales by Country (2015-2020) (K Units)
Table 56. Latin America ADHD Drugs Sales Market Share by Country (2015-2020)
Table 57. Latin Americaa ADHD Drugs Revenue by Country (2015-2020) (US$ Million)
Table 58. Latin America ADHD Drugs Revenue Market Share by Country (2015-2020)
Table 59. Latin America ADHD Drugs Sales by Type (2015-2020) (K Units)
Table 60. Latin America ADHD Drugs Sales Market Share by Type (2015-2020)
Table 61. Latin America ADHD Drugs Sales by Application (2015-2020) (K Units)
Table 62. Latin America ADHD Drugs Sales Market Share by Application (2015-2020)
Table 63. Middle East and Africa ADHD Drugs Sales by Country (2015-2020) (K Units)
Table 64. Middle East and Africa ADHD Drugs Sales Market Share by Country (2015-2020)
Table 65. Middle East and Africa ADHD Drugs Revenue by Country (2015-2020) (US$ Million)
Table 66. Middle East and Africa ADHD Drugs Revenue Market Share by Country (2015-2020)
Table 67. Middle East and Africa ADHD Drugs Sales by Type (2015-2020) (K Units)
Table 68. Middle East and Africa ADHD Drugs Sales Market Share by Type (2015-2020)
Table 69. Middle East and Africa ADHD Drugs Sales by Application (2015-2020) (K Units)
Table 70. Middle East and Africa ADHD Drugs Sales Market Share by Application (2015-2020)
Table 71. Eli Lilly Corporation Information
Table 72. Eli Lilly Description and Major Businesses
Table 73. Eli Lilly ADHD Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 74. Eli Lilly Product
Table 75. Eli Lilly Recent Development
Table 76. Janssen Pharmaceuticals, Inc. Corporation Information
Table 77. Janssen Pharmaceuticals, Inc. Description and Major Businesses
Table 78. Janssen Pharmaceuticals, Inc. ADHD Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 79. Janssen Pharmaceuticals, Inc. Product
Table 80. Janssen Pharmaceuticals, Inc. Recent Development
Table 81. Takeda Corporation Information
Table 82. Takeda Description and Major Businesses
Table 83. Takeda ADHD Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 84. Takeda Product
Table 85. Takeda Recent Development
Table 86. Perdue Pharma Corporation Information
Table 87. Perdue Pharma Description and Major Businesses
Table 88. Perdue Pharma ADHD Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 89. Perdue Pharma Product
Table 90. Perdue Pharma Recent Development
Table 91. Glaxosmith Kline Corporation Information
Table 92. Glaxosmith Kline Description and Major Businesses
Table 93. Glaxosmith Kline ADHD Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 94. Glaxosmith Kline Product
Table 95. Glaxosmith Kline Recent Development
Table 96. Novartis Corporation Information
Table 97. Novartis Description and Major Businesses
Table 98. Novartis ADHD Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 99. Novartis Product
Table 100. Novartis Recent Development
Table 101. Celltech Group Corporation Information
Table 102. Celltech Group Description and Major Businesses
Table 103. Celltech Group ADHD Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 104. Celltech Group Product
Table 105. Celltech Group Recent Development
Table 106. Johnson & Johnson Corporation Information
Table 107. Johnson & Johnson Description and Major Businesses
Table 108. Johnson & Johnson ADHD Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 109. Johnson & Johnson Product
Table 110. Johnson & Johnson Recent Development
Table 111. Global ADHD Drugs Sales Forecast by Regions (2021-2026) (K Units)
Table 112. Global ADHD Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 113. Global ADHD Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 114. Global ADHD Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 115. North America: ADHD Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 116. North America: ADHD Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 117. Europe: ADHD Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 118. Europe: ADHD Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 119. Asia Pacific: ADHD Drugs Sales Forecast by Region (2021-2026) (K Units)
Table 120. Asia Pacific: ADHD Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 121. Latin America: ADHD Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 122. Latin America: ADHD Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 123. Middle East and Africa: ADHD Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 124. Middle East and Africa: ADHD Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 125. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 126. Key Challenges
Table 127. Market Risks
Table 128. Main Points Interviewed from Key ADHD Drugs Players
Table 129. ADHD Drugs Customers List
Table 130. ADHD Drugs Distributors List
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. ADHD Drugs Product Picture
Figure 2. Global ADHD Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Stimulants (Amphetamines, Methylphenidate) Product Picture
Figure 4. Non-Stimulants Product Picture
Figure 5. Antidepressants Product Picture
Figure 6. Blood Pressure Medicines Product Picture
Figure 7. Global ADHD Drugs Sales Market Share by Application in 2020 & 2026
Figure 8. Adults
Figure 9. Children
Figure 10. ADHD Drugs Report Years Considered
Figure 11. Global ADHD Drugs Market Size 2015-2026 (US$ Million)
Figure 12. Global ADHD Drugs Sales 2015-2026 (K Units)
Figure 13. Global ADHD Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global ADHD Drugs Sales Market Share by Region (2015-2020)
Figure 15. Global ADHD Drugs Sales Market Share by Region in 2019
Figure 16. Global ADHD Drugs Revenue Market Share by Region (2015-2020)
Figure 17. Global ADHD Drugs Revenue Market Share by Region in 2019
Figure 18. Global ADHD Drugs Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by ADHD Drugs Revenue in 2019
Figure 20. ADHD Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global ADHD Drugs Sales Market Share by Type (2015-2020)
Figure 22. Global ADHD Drugs Sales Market Share by Type in 2019
Figure 23. Global ADHD Drugs Revenue Market Share by Type (2015-2020)
Figure 24. Global ADHD Drugs Revenue Market Share by Type in 2019
Figure 25. Global ADHD Drugs Market Share by Price Range (2015-2020)
Figure 26. Global ADHD Drugs Sales Market Share by Application (2015-2020)
Figure 27. Global ADHD Drugs Sales Market Share by Application in 2019
Figure 28. Global ADHD Drugs Revenue Market Share by Application (2015-2020)
Figure 29. Global ADHD Drugs Revenue Market Share by Application in 2019
Figure 30. North America ADHD Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 31. North America ADHD Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America ADHD Drugs Sales Market Share by Country in 2019
Figure 33. North America ADHD Drugs Revenue Market Share by Country in 2019
Figure 34. U.S. ADHD Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 35. U.S. ADHD Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada ADHD Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 37. Canada ADHD Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America ADHD Drugs Market Share by Type in 2019
Figure 39. North America ADHD Drugs Market Share by Application in 2019
Figure 40. Europe ADHD Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 41. Europe ADHD Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe ADHD Drugs Sales Market Share by Country in 2019
Figure 43. Europe ADHD Drugs Revenue Market Share by Country in 2019
Figure 44. Germany ADHD Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 45. Germany ADHD Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France ADHD Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 47. France ADHD Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. ADHD Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 49. U.K. ADHD Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy ADHD Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 51. Italy ADHD Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia ADHD Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 53. Russia ADHD Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe ADHD Drugs Market Share by Type in 2019
Figure 55. Europe ADHD Drugs Market Share by Application in 2019
Figure 56. Asia Pacific ADHD Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 57. Asia Pacific ADHD Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific ADHD Drugs Sales Market Share by Region in 2019
Figure 59. Asia Pacific ADHD Drugs Revenue Market Share by Region in 2019
Figure 60. China ADHD Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 61. China ADHD Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan ADHD Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 63. Japan ADHD Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea ADHD Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 65. South Korea ADHD Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India ADHD Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 67. India ADHD Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia ADHD Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 69. Australia ADHD Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan ADHD Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 71. Taiwan ADHD Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia ADHD Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 73. Indonesia ADHD Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand ADHD Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 75. Thailand ADHD Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia ADHD Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 77. Malaysia ADHD Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines ADHD Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 79. Philippines ADHD Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam ADHD Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 81. Vietnam ADHD Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific ADHD Drugs Market Share by Type in 2019
Figure 83. Asia Pacific ADHD Drugs Market Share by Application in 2019
Figure 84. Latin America ADHD Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 85. Latin America ADHD Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America ADHD Drugs Sales Market Share by Country in 2019
Figure 87. Latin America ADHD Drugs Revenue Market Share by Country in 2019
Figure 88. Mexico ADHD Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 89. Mexico ADHD Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil ADHD Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 91. Brazil ADHD Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina ADHD Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 93. Argentina ADHD Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America ADHD Drugs Market Share by Type in 2019
Figure 95. Latin America ADHD Drugs Market Share by Application in 2019
Figure 96. Middle East and Africa ADHD Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 97. Middle East and Africa ADHD Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa ADHD Drugs Sales Market Share by Country in 2019
Figure 99. Middle East and Africa ADHD Drugs Revenue Market Share by Country in 2019
Figure 100. Turkey ADHD Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 101. Turkey ADHD Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia ADHD Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 103. Saudi Arabia ADHD Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E ADHD Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 105. U.A.E ADHD Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa ADHD Drugs Market Share by Type in 2019
Figure 107. Middle East and Africa ADHD Drugs Market Share by Application in 2019
Figure 108. North America ADHD Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 109. North America ADHD Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 110. Europe ADHD Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 111. Europe ADHD Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Asia Pacific ADHD Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 113. Asia Pacific ADHD Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Latin America ADHD Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 115. Latin America ADHD Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Middle East and Africa ADHD Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 117. Middle East and Africa ADHD Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Porter's Five Forces Analysis
Figure 119. Channels of Distribution
Figure 120. Distributors Profiles
Figure 121. Bottom-up and Top-down Approaches for This Report
Figure 122. Data Triangulation
Figure 123. Key Executives Interviewed
注意欠陥多動性障害（ADHD）薬の世界市場（～2026年） Market Analysis and Insights: Global Attention Deficit Hyperactivity Disorder (ADHD) Drugs Market The global Attention Deficit Hyperactivity Disorder (ADHD) Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Attenti…- 注意欠陥・多動性障害（ADHD）の世界市場（～2026年） Attention Deficit Hyperactivity Disorder (ADHD) is a brain disorder marked by an ongoing pattern of inattention and/or hyperactivity-impulsivity that interferes with functioning or development. It may begin in early childhood and can continue into adulthood. Without treatment, ADHD can cause problem…
- 注意欠陥・多動性障害（ADHD）治療薬の世界市場（～2026年） ADHD is a brain/neurodevelopmental/neurobehavioral disorder characterized by pervasive and impairing symptoms of inattention, hyperactivity, and impulsivity. The Centers for Disease Control and Prevention (CDC) defines “neurobehavioral” as the way the brain affects emotion, behavior, and learning. G…
- 血液希釈剤の世界市場（～2026年） Market Analysis and Insights: Global Blood-thinning Drugs Market The global Blood-thinning Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Blood-thinning Drugs Scope and Market Size Blood-thinning Drugs market is…
- 血栓予防治療薬の世界市場（～2026年） Thrombosis is the process of blood clots that form in the artery or veins. In this thrombosis condition, a clot blocks the flow of blood in the affected area and can create serious complications such as myocardial infraction, Strokes atherosclerotic plaque, among others. Deep vein thrombosis is cond…